Findings from complementary approaches including RNA-seq RT-PCR and western blotting indicate that BETd-260 very efficiently inhibits the expression of Bcl-2 and Mcl-1 in HCC cells. The gene discussed is MCL1; the disease is hepatocellular carcinoma.